Cargando…
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
Type 2 diabetes mellitus (T2DM) is a progressive disease. After metformin failure, the addition of insulin or sulfonylureas might increase the risk of hypoglycemia and cardiovascular (CV) morbidity. Here, the risk of all-cause mortality was compared between early insulin treatment and glimepiride us...
Autores principales: | Yen, Fu-Shun, Hsu, Chih-Cheng, Su, Yuan-Chih, Wei, James Cheng-Chung, Hwu, Chii-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939219/ https://www.ncbi.nlm.nih.gov/pubmed/33655987 http://dx.doi.org/10.1097/MD.0000000000025085 |
Ejemplares similares
-
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
por: Yen, Fu‐Shun, et al.
Publicado: (2020) -
Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort study
por: Chin, Hyouk-Jun, et al.
Publicado: (2017) -
The relationships between thyroid-stimulating hormone level and insulin resistance, glucose effectiveness, first- and second-phase insulin secretion in Chinese populations
por: Chuang, Tsung-Ju, et al.
Publicado: (2021) -
Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016) -
Impact of high triglyceride/high-density lipoprotein cholesterol ratio (insulin resistance) in ST-segment elevation myocardial infarction
por: Chen, Huang-Chung, et al.
Publicado: (2020)